Trial intelligence / Profile preview

Steroid injection versus dextrose prolotherapy for chronic lateral epicondylitis

IRCT20170311033000N3Phase 3Completed

Sponsor
Shahid Beheshti University
Start
Aug 2017
Countries
1
01

Overview

Phase 3, double-blind trial of dextrose in Lateral Epicondylitis (LET) (2 arms), sponsored by Shahid Beheshti University. Primary endpoints: Pain intensity and Physical function and symptoms. Started Aug 2017; status: completed.

02

Drugs

dextrose
03

Conditions

Lateral Epicondylitis (LET)

Beyond the preview

Go deeper on IRCT20170311033000N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170311033000N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call